Cancer clinical trials in the region Grand Est

289 currently recruiting clinical trials
Region Grand Est

Phase 1 / Phase 2 Kidney cancer #NCT07049926 #2024-516437-12-00
Required histologic types
Clear cell carcinoma
Required disease stage
Locally Advanced Metastatic
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Immunotherapy
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
5 recruiting sites
Merck Sharp & Dohme LLC
Phase 1 / Phase 2 Bladder / Urinary Tract / Urethral cancer #NCT05706129 #2023-504254-35-00
Required histologic sub types
Urothelial carcinoma
Required disease stage
Locally Advanced Metastatic
Required number of previous lines of therapy for current stage of disease
1 2 3 or more
Required previous treatments at advanced or metastatic stage
Immunotherapy Chemotherapy Antibody Drug Conjugates (ADC)
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
8 recruiting sites
Debiopharm International SA
Phase 1 / Phase 2 Kidney cancer #NCT05706129 #2023-504254-35-00
Required histologic types
Clear cell carcinoma
Required disease stage
Locally Advanced Metastatic
Required number of previous lines of therapy for current stage of disease
2 3 or more
Required previous treatments at localized stage
Targeted therapy
Required previous treatments at advanced or metastatic stage
Immunotherapy Targeted therapy
8 recruiting sites
Debiopharm International SA
Phase 1 / Phase 2 Kidney cancer #NCT05706129 #2023-504254-35-00
Required histologic types
Other
Required disease stage
Localized
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Systemic Treatment-Naive
8 recruiting sites
Debiopharm International SA
Phase 1 / Phase 2 Pancreas cancer #NCT05706129 #2023-504254-35-00
Required histologic sub types
Adenocarcinoma
Required disease stage
Locally Advanced Metastatic
Required number of previous lines of therapy for current stage of disease
1 2 3 or more
Required previous treatments at advanced or metastatic stage
Chemotherapy
8 recruiting sites
Debiopharm International SA
Phase 1 / Phase 2 Colon cancer Rectal cancer #NCT05706129 #2023-504254-35-00
Required disease stage
Locally Advanced Metastatic
Required number of previous lines of therapy for current stage of disease
1 2 3 or more
Required previous treatments at advanced or metastatic stage
Chemotherapy Targeted therapy
8 recruiting sites
Debiopharm International SA
Phase 1 / Phase 2 Lymphoma #NCT07018752 #2024-514954-63-00
Required histologic types
T cell lymphoma
Required histologic sub types
Peripheral T cell lymphoma
Required central nervous system lesions
None
Required renal function statuses
> 60 ml/min 50-60 ml/min 30-50 ml/min
Required number of previous lines of therapy
1 2 3 or more
Excluded previous treatments
Systemic Treatment-Naive
13 recruiting sites
The Lymphoma Academic Research Organisation (LYSARC)
Phase 1 / Phase 2 Prostate cancer #NCT06353386 #2023-506288-33-00
Required histologic sub types
Adenocarcinoma
Required disease stage
Metastatic Castration-resistant
Required number of previous lines of therapy for current stage of disease
1 2 3 or more
Required previous treatments at localized stage
Hormone therapy
Required previous treatments at advanced or metastatic stage
Hormone therapy
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
4 recruiting sites
Merck Sharp & Dohme LLC
Not Applicable Sarcoma and GIST #NCT06081400
Required histologic types
Soft tissue sarcoma
Required disease stage
Localized
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Systemic Treatment-Naive
Excluded previous treatments at localized stage
Surgery Radiotherapy
11 recruiting sites
Hôpital universitaire, Strasbourg, France
Not Applicable Thymus cancer #NCT04731610
Required histologic types
Thymoma
Required disease stage
Localized
Required previous treatments at localized stage
Surgery
14 recruiting sites
Institut Curie